A local pancreatic renin-angiotensin system: Endocrine and exocrine roles

International Journal of Biochemistry and Cell Biology

Volumn 35, Issue 6, 2003, Pages 838-846

  Leung, Po Sing ^a   Chappell, Mark C ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Acinar cell; Endocrine; Exocrine; Islet cell; Pancreas; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN III; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FREE RADICAL; LOSARTAN; SARALASIN;

ACINAR CELL; AUTOCRINE EFFECT; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CYSTIC FIBROSIS; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ELECTROLYTE BALANCE; ENDOCRINE FUNCTION; EXOCRINE SECRETION; FLUID BALANCE; GROWTH; HORMONAL REGULATION; HORMONE ACTION; HUMAN; NONHUMAN; PANCREAS; PANCREAS CANCER; PANCREAS ISLET CELL; PANCREATITIS; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; FREE RADICALS; HUMANS; INSULIN; ISLETS OF LANGERHANS; OXIDATIVE STRESS; PANCREAS; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0037409231     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00179-6     Document Type: Review

References (63)

1. Reid I.A., Morris B.J., Ganong W.F. The renin-angiotensin system. Annu. Rev. Physiol. 40:1978;377-410.
2. De Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T.H. The angiotensin II receptors. Pharmacol. Rev. 52:2000;415-472.
3. Campbell D.J., Habener J. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 78:1986;31-39.
4. Campbell D.J. Circulating and tissue angiotensin systems. J. Clin. Invest. 79:1987;1-6.
5. Phillips M.I., Speakman E.A., Kimura B. Levels of angiotensin and molecular biology of the tissue renin-angiotensin system. Regul. Pept. 43:1993;1-20.
6. Leung P.S., Wong T.P., Sernia C. Angiotensinogen expression by rat epididymis: evidence for an intrinsic, angiotensin-generating system. Mol. Cell. Endocrinol. 155:1999;115-122.
7. Leung P.S., Wong T.P., Fung M.L., Sernia C. Chronic hypoxia induced down-regulation of angiotensinogen expression in the rat epididymis. Regul. Pept. 96:2000;143-149.
8. 1 receptor in rat carotid body. J. Endocrinol. 167:2000;517-524.
9. Lam S.Y., Leung P.S. A locally generated angiotensin system in rat carotid body. Regul. Pept. 107:2002;97-103.
10. Leung P.S., Carlsson P.O. Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J. Mol. Endocrinol. 26:2001;155-164.
11. Chappell M.C., Milsted A., Diz D.I., Brosnihan K.B., Ferrario C.M. Evidence for an intrinsic angiotensin system in the canine pancreas. J. Hypertens. 9:1991;751-759.
12. M.C. Chappell, D.I. Diz, D.W. Jacobsen, Pharmacological characterization of angiotensin II binding sites in the canine pancreas, Peptides (1992) 313-318.
13. 2 in the pancreas of rodents. J. Endocrinol. 153:1997;269-274.
14. Leung P.S., Chan H.C., Wong P.Y.D. Immunohistochemical localization of angiotensin II in the mouse pancreas. Histochem. J. 30:1998;21-25.
15. Leung P.S., Chan W.P., Wong T.P., Sernia C. Expression and localization of renin-angiotensin system in the rat pancreas. J. Endocrinol. 160:1999;13-19.
16. Tahmasebi M., Puddefoot J.R., Inwang E.R., Vinson G.P. The tissue renin-angiotensin system in human pancreas. J. Endocrinol. 161:1999;317-322.
17. Chan W.P., Fung M.L., Nobiling R., Leung P.S. Activation of local renin-angiotensin system by chronic hypoxia. Mol. Cell. Endocrinol. 160:2000;107-114.
18. Leung P.S., Chan W.P., Nobiling R. Regulated expression of pancreatic renin-angiotensin system in experimental pancreatitis. Mol. Cell. Endocrinol. 166:2000;121-128.
19. Lam K.Y., Leung P.S. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur. J. Endocrinol. 146:2002;567-572.
20. S.P. Ip, W.Y. Chan, P.S. Leung, Effects of chronic hypoxia on the circulating and pancreatic renin-angiotensin system, Pancreas 25 (2002).
21. Chappell M.C., Diz D.I., Gallagher P.E. The renin-angiotensin system and the exocrine pancreas. JOP. 2:2001;33-39.
22. Chappell M.C., Neves L., Brosnihan K.B., Gallagher P.E. Pancreatic AR42J acinar cells express all components of a renin-angiotensin system. FASEB J. 15:2001;A820.
23. Fishel R.S., Eisenberg S., Shai S.Y., Redden R.A., Bernstein K.E., Berk B.C. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension. 25:1995;343-349.
24. Brasier A.R., Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 27:1996;465-475.
25. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robinson K., Jeyaseelan R., Breitbart R.E., Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87:2000;1-9.
26. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277:2002;14838-14843.
27. M.C. Chappell, E.A. Tallant, D.I. Diz, C.M. Ferrari, The renin-angiotensin system and cardiovascular homeostasis, in: A. Husain, R.M. Graham (Eds.), Drugs, Enzymes and Receptors of the Renin-Angiotensin System: Celebrating a Century of Discovery, Harwood Academic Publishers, Amsterdam, 2000, pp. 3-22.
28. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., Oliveira-dos-Santo A.J., da Costa J., Zhang L., Pei Y., Scholey J., Bray M.R., Ferrario C.M., Backx P.H., Manoukian A.S., Chappell M.C., Yagi Y., Penninger J.M. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417:2002;822-828.
29. 2 angiotensin II receptors in the primate and rat pancreas. J. Hypertens. 12:1994;S181.
30. C Chappell M., Jacobsen D.W., Tallant E.A. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides. 16:1995;741-747.
31. Takahasi K., Bardhan S., Kambayashi Y., Shirai H., Inagami T. Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor. Biochem. Biophys. Res. Commun. 198:1994;60-66.
32. 2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem. Biophys. Res. Commun. 183:1992;206-211.
33. 2 receptor. Mol. Endocrinol. 14:2000;795-804.
34. 1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10663-10667.
35. Huang X.C., Richards E.M., Summer C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J. Biol. Chem. 271:1996;15635-15641.
36. 2 receptor. Kidney Int. 53:1998;92-99.
37. 2: new mechanisms of signaling and antagonistic effects. Jpn. Circ. J. 61:1997;807-813.
38. Lever A.F., Hole D.J., Gillis C.R., McCallum I.R., McInnes G.T., MacKinnon P.L., Meredith P.A., Murray L.S., Reid J.L., Robertson J.W.K. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet. 352:1998;179-184.
39. Reddy M.K., Baskaran K., Molteni A. Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc. Soc. Exp. Biol. Med. 210:1995;221-226.
40. Tallant E.A., Diz D.I., Ferrario C.M. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 34:1999;950-957.
41. Strawn W.B., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 33:1999;207-211.
42. Chappell M.C., Iyer S.N., Diz D.I., Ferrario C.M. Antihypertensive effects of angiotensin-(1-7). Braz. J. Med. Biol. Res. 31:1998;1205-1212.
43. Iyer S.N., Yamada K., Diz D.I., Ferrario C.M., Chappell M.C. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J. Cardiovas. Pharmacol. 36:2000;109-117.
44. Tsutsumi Y., Matsubara H., Masaki H., Kurihara H., Murasawa S., Takai S., Miyazaki M., Nozawa Y., Ozono R., Nakagawa K., Miwa T., Kawada N., Mori Y., Shibasaki Y., Tanaka Y., Fujiyama S., Koyama Y., Fujiyama A., Takahashi H., Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104:1999;925-935.
45. Abbas A., Gorelik G., Carbini L.A., Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 30:1997;217-221.
46. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., Santos R.A.S. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension. 30:1997;542-548.
47. Deddish P.A., Marcic B., Jackman H.L., Wang H.Z., Skidgel R.A., Erdos E.G. N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme. Hypertension. 31:1998;912-917.
48. Marcic B., Deddish P.A., Jackman H.L., Erdos E.G. Enhancement of bradykinin and resensitization of its B2 receptor. Hypertension. 33:1999;835-843.
49. Hata A. Role of angiotensinogen in the genetics of essential hypertension. Life Sci. 57:1995;2385-2395.
50. Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. New Engl. J. Med. 321:1989;868-873.
51. Santoro D., Natal A., Palombo C., Brandi L.S., Piatti M., Ghione S., Ferrannini E. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension. 20:1992;181-191.
52. Carlsson P.O., Berne C., Jansson L. Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia. 41:1998;127-133.
53. Olsson R., Jansson L., Andersson A., Carlsson P.O. Local blood flow regulation in transplanted rat pancreatic islets: influence of adenosine, angiotensin II and nitric oxide inhibition. Transplantation. 70:2000;280-287.
54. Carlsson P.O., Liss P., Andersson A., Jansson L. Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes. 47:1988;1027-1032.
55. Carlsson P.O., Palm F., Andersson A., Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes. 50:2001;489-495.
56. Ip S.P., Chan Y.W., Che C.T., Leung P.S. Effect of chronic hypoxia on glutathione status and membrane integrity in the pancreas. Pancreatology. 2:2002;34-39.
57. Dijkhorst-Oei L.T., Stroes E.S., Koomans H.A., Rabelink T.J. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo. J. Cardiovasc. Pharmacol. 33:1999;420-424.
58. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
59. Jaimes E.A., Galceran J.M., Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 54:1998;775-784.
60. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Brasen J.H., Skatchkov M., Heitzer T., Stasch J.P., Griendling K.K., Harrison D.G., Bohm M., Meinertz T., Munzel T. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 99:1999;2027-2033.
61. Pagano P.J., Chanock S.J., Siwik D.A., Colucci W.S., Clark J.K. Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 32:1998;331-337.
62. S.P. Ip, S.W. Tsang, T.P. Wong, C.T. Che, P.S. Leung, Saralasin a non-specific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis, Pancreas, submitted for publication.
63. Allred A.J., Chappell M.C., Ferrario C.M., Diz D.I. Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am. J. Physiol. 279:2000;636-645.